• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechansim

ABPI_Incentivising_Antibioics_peter-pryharski-unsplash_landscape
Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • Insight
11 min read 28th April 2020

The Digitalisation of Health Care During COVID-19: Consideration of the Long-Term Consequences

The need for social distancing in light of COVID-19 has led to an unprecedented increase in reliance on digital technologies by both health care providers and patients. While the trend towards digitalisation of health care allows for potential improvements in…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The need for social distancing in light of COVID-19 has led to an unprecedented increase in reliance on digital technologies by both health care providers and patients. While the trend towards digitalisation of health care allows for potential improvements in access, its impact on health outcomes and health inequalities must be carefully considered to ensure they contribute to social welfare and not detract from it.

The need for social distancing in light of COVID-19 has led to an unprecedented increase in reliance on digital technologies by both health care providers and patients. While the trend towards digitalisation of health care allows for potential improvements in access, its impact on health outcomes and health inequalities must be carefully considered to ensure they contribute to social welfare and not detract from it.

The outbreak of COVID-19 – declared by the World Health Organisation (WHO) as a pandemic in early 2020 – has affected every aspect of everyday life. In the UK – as in many other countries – social distancing has been implemented as a key strategy in the effort to slow the spread of the virus. While visiting the doctor is technically permitted under these rules, overstretched health systems, along with the need to minimise risk of contagion, means that gaining access to medical professionals has become extremely challenging. This is expected to have significant consequences on overall health outcomes – and thus welfare – not only for those directly affected by COVID-19, but also those for whom vital support from health care providers has been severely limited as a result of the surge in demand.

Digitalisation as a solution

In light of this, there has been an increase in attention towards the potential of digital technologies in the health care space as they offer a means of addressing this problem: for example, in England the NHS app allows patients to take more control over their own health care (e.g. by managing their own prescriptions) thus easing demand on the system. Users of this app doubled over the month of March, reflecting the increased reliance on digital technologies while social distancing measures are in place. Other telehealth services, such as consultations via video link offer a way of maintaining the supply of essential services while avoiding the risk of contagion in waiting rooms. Therefore, the potential of digital technologies to improve access to health care is now – in the midst of COVID-19 – more welcome than ever.

Digitalisation of health care services is not a brand new phenomenon. In recent years there has been an ever-increasing number of mobile applications (apps) being developed and marketed. These range from relatively simple technologies with no measurable patient outcomes, to complex products that guide or even provide treatment (and which may be classified and regulated as medical devices). In 2019, Digital Health Technologies (DHTs) were postulated to go mainstream in the NHS Long Term Plan. This growth in reliance on digital technologies should not be without scrutiny of their safety and efficacy alongside any perceived efficiency gains. The advice provided through the evidence standards framework for digital health technologies by NICE and the NHS assessment of apps and digital tools are useful starting points to ensure that future digital innovations are assessed on evidence for costs and outcomes in a similar manner as other health interventions.

The long-term effects of DHTs on health outcomes are less clear. Although to date there has been little evidence of apparent negative effects from increased use of digital technologies, this may not necessarily hold true in the long run. For example, it is unclear whether consultations using telehealth methods provide the same level of care and patient experience as in-person appointments, which in turn may lead to sub-optimal health outcomes. Alternatively, if a patient becomes overly dependent on DHTs to manage their own health, they may avoid going to the doctor, which has the risk of leading to mismanagement and poorer health outcomes. In light of the increased usage of DHTs during COVID-19, the evaluation of their overall impact requires consideration not only of their direct effects but also of any unintended spill-over effects.

Who will benefit? Who will miss out?

On a wider societal level, there is need to ensure that, where there are benefits to be gained from the digitalisation of health care, such benefits are distributed in a manner that does not exacerbate or create health-related inequalities. Since digital technologies became mainstream, it is well-documented that the uptake of such technologies is not uniform across different groups in society (Brodie et al., 2000). According to the Consumer Digital Index 2019, 4.1 (8%) million adults in the UK are offline, and 1.9 million people (22%) do not have the essential digital skills needed for day-to-day life. Digital disengagement is also found to be higher amongst older people from minority ethnic backgrounds. Thus, there is an imminent risk that improvements to health outcomes resulting from the digitalisation of health care will accrue only to those who are more willing and/or able to engage.

Therefore, digital inequality may lead to DHT-induced health inequalities. Existing health inequalities may become exacerbated, as people who are less able to benefit from DHTs are generally those already in disadvantaged groups. Furthermore, the shift to digitalisation may lead to a redistribution of resources away from non-users of DHTs. Evidence from India suggest that the adoption of digital technologies can come at the expense of non-users as health care professionals change their response in favour of the users (Haenssgen, 2018). It is therefore possible that digitalisation and COVID-19 benefits accruing to one group will come at the expense of other, less well-off groups.

Making it work in the long run

There is no doubt that DHTs bear great potential for improving health outcomes and increasing efficiency in health care markets, especially in times of surge demand. However, more work is needed to ensure the fair distribution of their benefits. This comprises more qualitative research on if and how patients and physicians engage with digital technologies. We need to better understand digitally-induced health inequalities and whether or not digital inclusion can mitigate them. Secondly, quantitative research is required to gain more knowledge about causal relationships of different DHTs used by health care professionals and/or patients, and related health outcomes. In particular, we need to understand how these effects differ between socio-demographic and socioeconomic groups, especially those with protected characteristics.

The NICE evidence framework for DHTs advises innovators to consider the role of their idea with respect to health inequalities. Equality impact assessments are also carried out for DHTs running within the Digital health technologies pilot with the aim to develop dedicated future guidance on DHTs. Given the current ‘shock in digitalisation’ – the time is now to make this role an inclusive one.

Related Research:

Brodie, M., Flournoy, R.E., Altman, D.E., Blendon, R.J., Benson, J.M. and Rosenbaum, M.D., 2000. Health Information, The Internet, And The Digital Divide. Health Affairs, 19(6), pp.255–265. 10.1377/hlthaff.19.6.255.

Haenssgen, M.J., 2018. The struggle for digital inclusion: Phones, healthcare, and marginalisation in rural India. World Development, 104, pp.358–374. 10.1016/j.worlddev.2017.12.023.

 

  • COVID-19 Research
  • Value, Affordability, and…
  • Innovation

Related Insights

Eye-Disease Gene-Therapies blog
  • Insight
  • February 2023

Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?

Read more
Fishing on the lake at sunset. Fishing background.
  • Insight
  • February 2023

Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges

Read more
G7Antibiotics_blog_featuredimage
  • Insight
  • December 2022

G7 Investments in New Antibiotics Would Pay Off – For Everyone

Read more
Slide3
  • Insight
  • October 2022

The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!